News Conference News TCT 2025 TTVR Remains Safe, Effective in Presence of CIED Leads Todd Neale October 25, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Conference News HRS 2025 Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe Todd Neale April 28, 2025
News Daily News Patient-Centric Outcomes Embraced by Global Heart Valve Experts L.A. McKeown February 24, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Daily News Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research Yael L. Maxwell December 12, 2022
News Daily News Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes Yael L. Maxwell December 06, 2022
News Daily News Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes Michael O'Riordan September 13, 2022
News Conference News ACC 2022 Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR Yael L. Maxwell April 05, 2022
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Industry News Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures March 01, 2016
CME Tricuspid Regurgitation: Burden of Disease, Recent Evidence for Transcatheter Therapies, and How to Best Measure Success for TR Patients